FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
From the launch
For 60 years, drug discovery has chased proteins. But ~85% of disease drivers don't have a druggable protein, making them unreachable for modern medicine. The deeper issue: most disease doesn't start at the protein, it starts in the DNA that codes for it. We built a programmable drug that reads DNA inside the cell, decides if it's diseased, and destroys the cell if it is. One platform, reprogrammed to any disease distinguishable on a DNA level. In the future, we believe this is the most general curative modality for any somatic mutation driven disease ever existed. This will be the basis of a new era for genome-addressable medicine. FinalDose: YC Spring 2026: FinalDose: The first programmable drug to cure all cancers
